HealthEquity Company Equity Multiplier from 2010 to 2024

HQY Stock  USD 94.95  0.19  0.20%   
HealthEquity Company Equity Multiplier yearly trend continues to be fairly stable with very little volatility. Company Equity Multiplier will likely drop to 1.18 in 2024. During the period from 2010 to 2024, HealthEquity Company Equity Multiplier regression line of annual values had r-squared of  0.1 and arithmetic mean of  1.43. View All Fundamentals
 
Company Equity Multiplier  
First Reported
2010-12-31
Previous Quarter
1.55467192
Current Value
1.18
Quarterly Volatility
0.40537511
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.7 M, Interest Expense of 58.2 M or Selling General Administrative of 108.8 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.64. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
  
Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Latest HealthEquity's Company Equity Multiplier Growth Pattern

Below is the plot of the Company Equity Multiplier of HealthEquity over the last few years. It is HealthEquity's Company Equity Multiplier historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
Company Equity Multiplier10 Years Trend
Slightly volatile
   Company Equity Multiplier   
       Timeline  

HealthEquity Company Equity Multiplier Regression Statistics

Arithmetic Mean1.43
Geometric Mean1.38
Coefficient Of Variation28.41
Mean Deviation0.32
Median1.30
Standard Deviation0.41
Sample Variance0.16
Range1.4241
R-Value0.31
Mean Square Error0.16
R-Squared0.1
Significance0.25
Slope0.03
Total Sum of Squares2.30

HealthEquity Company Equity Multiplier History

2024 1.18
2023 1.55
2022 1.63
2021 1.68
2020 1.97
2019 2.49

About HealthEquity Financial Statements

HealthEquity investors use historical fundamental indicators, such as HealthEquity's Company Equity Multiplier, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Company Equity Multiplier 1.55  1.18 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.